By Maria Hoven – Updated Aug 30, 2022
Genetic engineering is a branch of molecular biology that involves the precise manipulation of DNA – the deoxyribonucleic acid that encodes all biological traits. By introducing, deleting, or modifying specific genes, scientists can reprogram organisms for research, medicine, or industry.
Recombinant DNA, or rDNA, refers to a synthetic DNA molecule created by joining genetic fragments from different sources. Unlike naturally occurring DNA, rDNA is engineered in a laboratory to carry specific genes that encode desired proteins.
The construction of rDNA relies on restriction enzymes that cut DNA at precise sequences, and DNA ligase that seals the cuts, joining fragments from disparate origins. The resulting plasmid—an independent circular DNA—can be inserted into a host cell, most commonly E. coli, where it is replicated and the encoded protein is expressed. This process is detailed in H. Lodish et al., “Molecular Cell Biology.”
In 1973, scientists Paul Berg, Herbert Boyer, Annie Chang, and Stanley Cohen produced the first functional rDNA molecules at Stanford University and UCSF. Their breakthrough marked the birth of genetic engineering, as noted in Gerald Karp, “Cell and Molecular Biology.”
Recombinant DNA technology enables the production of therapeutic proteins in the lab, eliminating the need to harvest them from animals. Examples include human insulin—previously extracted from porcine or bovine pancreas—and growth hormones, as well as a wide range of vaccines. These advances have revolutionized medicine and improved patient safety.
Genetic engineering cannot exist without recombinant DNA; rDNA provides the tools for gene transfer, expression, and modification that underpin every modern biotechnological application.
